Posted On: 09/07/2013 11:37:14 AM
Post# of 250679
Provectus Pharmaceutical, Inc. PVCT Company Overview
Stock Message Board http://investorshangout.com/search?q=PVCT&...mp;yt1=Go!
Provectus Pharmaceutical, Inc. PVCT Current Price and Quotes
Last Price 0.7401
Previous Close 0.75 Open 0.74
Daily Range 0.80 - 0.74 52wk Range 0.895 - 0.431
Volume 670,464 Dividend N/A
Average Vol (3m) 167,110 Yield N/A
Provectus Pharmaceutical, Inc. PVCT
Company Verified Profile
Company Information
7327 Oak Ridge Highway
Suite A
Knoxville, TN 37931
Website: http://www.pvct.com
Phone: 866-594-5999
Email: pete@pvct.com
Provectus Pharmaceutical, Inc. PVCT
Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. Its dermatological dr...
Provectus Pharmaceutical, Inc. PVCT
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000315545
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Dec 31, 2010
Incorporated In: NV, USA
Year of Inc. 2002
Employees Not Available
Company Officers/Contacts
H. Craig Dees Ph.D. CEO
Timothy C. Scott, Ph.D. President
Peter Culpepper CFO, COO
Eric Wachter CTO
Marlon Nurse IR, SVP, Inv. Rel.
Company Directors
H. Craig Dees Ph.D. Chairman
Alfred E. Smith, IV
Jan E. Koe
Company Notes
Formerly=Zamage Digital Imaging, Inc. until 4-02
Note=4-1-02 State of Incorporation Colorado changed to Nevada
Note=12-31-04 company is in the development stage
Formerly=SPM Group, Inc. until 11-01
Service Providers
Auditor/Accountant
BDO
Zurich,
Legal Counsel
Baker, Donelson, Bearman, Caldwell and Berkowitz, PC
165 Madison Ave.
Memphis, TN, 38103
United States
Investor Relations Firm
Porter, LeVay & Rose
7 Penn Plaza
New York, NY, 10001
United States
Network 1 Financial Securities
The Galleria Building, 2 Bridge Avenue
Red Bank, NJ, 07701
United States
Provectus Pharmaceutical, Inc. PVCT
PVCT Security Details
Share Structure
Market Value1 $95,195,078 a/o Sep 06, 2013
Shares Outstanding 128,624,615 a/o Jun 30, 2013
Float 95,000,000 a/o Jul 15, 2013
Authorized Shares 250,000,000 a/o Jul 15, 2013
Par Value 0.001
Shareholders
Shareholders of Record 1,448 a/o Mar 14, 2013
Security Notes
New Issue=7-80 3,000,000 shs at $1 (best efforts-2,000,000 min.) by Blinder, Robinson & Co., Inc.
Capital Change=shs decreased by 1 for 5000 split. Pay date=06/28/2000.
Capital Change=shs decreased by 1 for 300 split. Pay date=04/11/2002.
Short Selling Data
Short Interest 1,323,019 (-0.04%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Broadridge Financial Solutions, Inc.
Provectus Pharmaceutical, Inc. PVCT Recent News
Sept 7, 2013 OTC Signal Daily Stock Watch - (OTCQB: PVCT)
Sept 4, 2013 OtcbbJournal.com Delivers the Most Sought After Micro-Cap Stock Research in the Business
Aug 6, 2013 Research on Mechanism of Action of Rose Bengal Presented at 8th World Congress of Melanoma
Jul 25, 2013 PV-10's Systemic Tumor-Specific Immune Response is Subject of Research Article Published in PLOS ONE
Jun 24, 2013 PV-10 Data on Locoregional Disease Control in Metastatic Melanoma to Be Presented at European Cancer Congress 2013
Provectus Pharmaceutical, Inc. PVCT Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 5,005 8,808 8,417 4,909
Sales, General and Admin. 8,661 11,962 11,605 6,746
Non-Recurring Items - - - -
Other 671 671 671 671
Operating Income (14,338) (21,441) (20,693) (12,326)
Income From Continuing Operations
Add'l Income/Expense Items 1,769 2,006 2,141 4
Earnings Before Interest and Tax (12,568) (19,435) (18,552) (12,322)
Interest Expense - - - -
Earnings Before Tax (12,568) (19,435) (18,552) (12,322)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (12,568) (19,435) (18,552) (12,322)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (12,568) (19,435) (18,552) (12,322)
Preferred Stock and Other Adjustments (183) (247) (10,408) -
Net Income Applicable to Common Shareholders (12,752) (19,682) (28,960) (12,322)
PVCT Provectus Pharmaceutical, Inc. Research DD Guide
PVCT Provectus Pharmaceutical, Inc. Stock Message Board http://investorshangout.com/search?q=PVCT&...mp;yt0=Go!
PVCT Provectus Pharmaceutical, Inc. Stock Quote http://www.otcmarkets.com/stock/PVCT/quote
PVCT Provectus Pharmaceutical, Inc. Stock Chart http://www.otcmarkets.com/stock/PVCT/chart
PVCT Provectus Pharmaceutical, Inc. Company Info http://www.otcmarkets.com/stock/PVCT/company-info
PVCT Provectus Pharmaceutical, Inc. Recent News http://www.otcmarkets.com/stock/PVCT/news
PVCT Provectus Pharmaceutical, Inc. Financials http://www.otcmarkets.com/stock/PVCT/financials
PVCT Provectus Pharmaceutical, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/PVCT/filings
PVCT Provectus Pharmaceutical, Inc. Short Sales http://www.otcmarkets.com/stock/PVCT/short-sales
PVCT Provectus Pharmaceutical, Inc. Insider Disclosure http://www.otcmarkets.com/stock/PVCT/insider-transactions
PVCT Provectus Pharmaceutical, Inc. Research Reports http://www.otcmarkets.com/stock/PVCT/research
PVCT Provectus Pharmaceutical, Inc. Summary http://finance.yahoo.com/q?s=PVCT
PVCT Provectus Pharmaceutical, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=PVCT+Historical+Prices
PVCT Provectus Pharmaceutical, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=PVCT
PVCT Provectus Pharmaceutical, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=PVCT+Basic+Chart
PVCT Provectus Pharmaceutical, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PVCT+Basic+Tech.+Analysis
PVCT Provectus Pharmaceutical, Inc. Headlines http://finance.yahoo.com/q/h?s=PVCT+Headlines
PVCT Provectus Pharmaceutical, Inc. Press Releases http://finance.yahoo.com/q/p?s=PVCT+Press+Releases
PVCT Provectus Pharmaceutical, Inc. Company Profile http://finance.yahoo.com/q/pr?s=PVCT+Profile
PVCT Provectus Pharmaceutical, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=PVCT+Key+Statistics
PVCT Provectus Pharmaceutical, Inc. Industry http://finance.yahoo.com/q/in?s=PVCT+Industry
PVCT Provectus Pharmaceutical, Inc. Major Holders http://finance.yahoo.com/q/mh?s=PVCT+Major+Holders
PVCT Provectus Pharmaceutical, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=PVCT+Insider+Transactions
PVCT Provectus Pharmaceutical, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=PVCT+Insider+Roster
PVCT Provectus Pharmaceutical, Inc. Income Statement http://finance.yahoo.com/q/is?s=PVCT
PVCT Provectus Pharmaceutical, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=PVCT
PVCT Provectus Pharmaceutical, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=PVCT+Cash+Flow&annual
PVCT Provectus Pharmaceutical, Inc. Nasdaq http://www.nasdaq.com/symbol/PVCT
PVCT Provectus Pharmaceutical, Inc. Market Watch http://www.marketwatch.com/investing/stock/PVCT
PVCT Provectus Pharmaceutical, Inc. Bloomberg http://www.bloomberg.com/quote/PVCT:US
PVCT Provectus Pharmaceutical, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=PVCT
PVCT Provectus Pharmaceutical, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=PVCT
PVCT Provectus Pharmaceutical, Inc. Barchart http://www.barchart.com/quotes/stocks/PVCT
PVCT Provectus Pharmaceutical, Inc. OTC Short Report http://otcshortreport.com/index.php?index=PVCT
PVCT Provectus Pharmaceutical, Inc. Investopedia http://www.investopedia.com/markets/stocks/PVCT/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Stock Message Board http://investorshangout.com/search?q=PVCT&...mp;yt1=Go!
Provectus Pharmaceutical, Inc. PVCT Current Price and Quotes
Last Price 0.7401
Previous Close 0.75 Open 0.74
Daily Range 0.80 - 0.74 52wk Range 0.895 - 0.431
Volume 670,464 Dividend N/A
Average Vol (3m) 167,110 Yield N/A
Provectus Pharmaceutical, Inc. PVCT
Company Verified Profile
Company Information
7327 Oak Ridge Highway
Suite A
Knoxville, TN 37931
Website: http://www.pvct.com
Phone: 866-594-5999
Email: pete@pvct.com
Provectus Pharmaceutical, Inc. PVCT
Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. Its dermatological dr...
Provectus Pharmaceutical, Inc. PVCT
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000315545
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Dec 31, 2010
Incorporated In: NV, USA
Year of Inc. 2002
Employees Not Available
Company Officers/Contacts
H. Craig Dees Ph.D. CEO
Timothy C. Scott, Ph.D. President
Peter Culpepper CFO, COO
Eric Wachter CTO
Marlon Nurse IR, SVP, Inv. Rel.
Company Directors
H. Craig Dees Ph.D. Chairman
Alfred E. Smith, IV
Jan E. Koe
Company Notes
Formerly=Zamage Digital Imaging, Inc. until 4-02
Note=4-1-02 State of Incorporation Colorado changed to Nevada
Note=12-31-04 company is in the development stage
Formerly=SPM Group, Inc. until 11-01
Service Providers
Auditor/Accountant
BDO
Zurich,
Legal Counsel
Baker, Donelson, Bearman, Caldwell and Berkowitz, PC
165 Madison Ave.
Memphis, TN, 38103
United States
Investor Relations Firm
Porter, LeVay & Rose
7 Penn Plaza
New York, NY, 10001
United States
Network 1 Financial Securities
The Galleria Building, 2 Bridge Avenue
Red Bank, NJ, 07701
United States
Provectus Pharmaceutical, Inc. PVCT
PVCT Security Details
Share Structure
Market Value1 $95,195,078 a/o Sep 06, 2013
Shares Outstanding 128,624,615 a/o Jun 30, 2013
Float 95,000,000 a/o Jul 15, 2013
Authorized Shares 250,000,000 a/o Jul 15, 2013
Par Value 0.001
Shareholders
Shareholders of Record 1,448 a/o Mar 14, 2013
Security Notes
New Issue=7-80 3,000,000 shs at $1 (best efforts-2,000,000 min.) by Blinder, Robinson & Co., Inc.
Capital Change=shs decreased by 1 for 5000 split. Pay date=06/28/2000.
Capital Change=shs decreased by 1 for 300 split. Pay date=04/11/2002.
Short Selling Data
Short Interest 1,323,019 (-0.04%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Broadridge Financial Solutions, Inc.
Provectus Pharmaceutical, Inc. PVCT Recent News
Sept 7, 2013 OTC Signal Daily Stock Watch - (OTCQB: PVCT)
Sept 4, 2013 OtcbbJournal.com Delivers the Most Sought After Micro-Cap Stock Research in the Business
Aug 6, 2013 Research on Mechanism of Action of Rose Bengal Presented at 8th World Congress of Melanoma
Jul 25, 2013 PV-10's Systemic Tumor-Specific Immune Response is Subject of Research Article Published in PLOS ONE
Jun 24, 2013 PV-10 Data on Locoregional Disease Control in Metastatic Melanoma to Be Presented at European Cancer Congress 2013
Provectus Pharmaceutical, Inc. PVCT Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 5,005 8,808 8,417 4,909
Sales, General and Admin. 8,661 11,962 11,605 6,746
Non-Recurring Items - - - -
Other 671 671 671 671
Operating Income (14,338) (21,441) (20,693) (12,326)
Income From Continuing Operations
Add'l Income/Expense Items 1,769 2,006 2,141 4
Earnings Before Interest and Tax (12,568) (19,435) (18,552) (12,322)
Interest Expense - - - -
Earnings Before Tax (12,568) (19,435) (18,552) (12,322)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (12,568) (19,435) (18,552) (12,322)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (12,568) (19,435) (18,552) (12,322)
Preferred Stock and Other Adjustments (183) (247) (10,408) -
Net Income Applicable to Common Shareholders (12,752) (19,682) (28,960) (12,322)
PVCT Provectus Pharmaceutical, Inc. Research DD Guide
PVCT Provectus Pharmaceutical, Inc. Stock Message Board http://investorshangout.com/search?q=PVCT&...mp;yt0=Go!
PVCT Provectus Pharmaceutical, Inc. Stock Quote http://www.otcmarkets.com/stock/PVCT/quote
PVCT Provectus Pharmaceutical, Inc. Stock Chart http://www.otcmarkets.com/stock/PVCT/chart
PVCT Provectus Pharmaceutical, Inc. Company Info http://www.otcmarkets.com/stock/PVCT/company-info
PVCT Provectus Pharmaceutical, Inc. Recent News http://www.otcmarkets.com/stock/PVCT/news
PVCT Provectus Pharmaceutical, Inc. Financials http://www.otcmarkets.com/stock/PVCT/financials
PVCT Provectus Pharmaceutical, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/PVCT/filings
PVCT Provectus Pharmaceutical, Inc. Short Sales http://www.otcmarkets.com/stock/PVCT/short-sales
PVCT Provectus Pharmaceutical, Inc. Insider Disclosure http://www.otcmarkets.com/stock/PVCT/insider-transactions
PVCT Provectus Pharmaceutical, Inc. Research Reports http://www.otcmarkets.com/stock/PVCT/research
PVCT Provectus Pharmaceutical, Inc. Summary http://finance.yahoo.com/q?s=PVCT
PVCT Provectus Pharmaceutical, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=PVCT+Historical+Prices
PVCT Provectus Pharmaceutical, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=PVCT
PVCT Provectus Pharmaceutical, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=PVCT+Basic+Chart
PVCT Provectus Pharmaceutical, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PVCT+Basic+Tech.+Analysis
PVCT Provectus Pharmaceutical, Inc. Headlines http://finance.yahoo.com/q/h?s=PVCT+Headlines
PVCT Provectus Pharmaceutical, Inc. Press Releases http://finance.yahoo.com/q/p?s=PVCT+Press+Releases
PVCT Provectus Pharmaceutical, Inc. Company Profile http://finance.yahoo.com/q/pr?s=PVCT+Profile
PVCT Provectus Pharmaceutical, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=PVCT+Key+Statistics
PVCT Provectus Pharmaceutical, Inc. Industry http://finance.yahoo.com/q/in?s=PVCT+Industry
PVCT Provectus Pharmaceutical, Inc. Major Holders http://finance.yahoo.com/q/mh?s=PVCT+Major+Holders
PVCT Provectus Pharmaceutical, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=PVCT+Insider+Transactions
PVCT Provectus Pharmaceutical, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=PVCT+Insider+Roster
PVCT Provectus Pharmaceutical, Inc. Income Statement http://finance.yahoo.com/q/is?s=PVCT
PVCT Provectus Pharmaceutical, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=PVCT
PVCT Provectus Pharmaceutical, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=PVCT+Cash+Flow&annual
PVCT Provectus Pharmaceutical, Inc. Nasdaq http://www.nasdaq.com/symbol/PVCT
PVCT Provectus Pharmaceutical, Inc. Market Watch http://www.marketwatch.com/investing/stock/PVCT
PVCT Provectus Pharmaceutical, Inc. Bloomberg http://www.bloomberg.com/quote/PVCT:US
PVCT Provectus Pharmaceutical, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=PVCT
PVCT Provectus Pharmaceutical, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=PVCT
PVCT Provectus Pharmaceutical, Inc. Barchart http://www.barchart.com/quotes/stocks/PVCT
PVCT Provectus Pharmaceutical, Inc. OTC Short Report http://otcshortreport.com/index.php?index=PVCT
PVCT Provectus Pharmaceutical, Inc. Investopedia http://www.investopedia.com/markets/stocks/PVCT/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
(0)
(0)
